146 related articles for article (PubMed ID: 10453907)
1. Bendectin: review of the medical literature of a comprehensively studied human nonteratogen and the most prevalent tortogen-litigen.
Scialli AR
Reprod Toxicol; 1999; 13(4):239. PubMed ID: 10453907
[No Abstract] [Full Text] [Related]
2. Response to Dr. Stuart Newman's commentary on an article entitled "Bendectin: review of the medical literature of a comprehensively studied human nonteratogen and the most prevalent tortogen-litigen".
Brent RL
Reprod Toxicol; 1999; 13(4):245-53. PubMed ID: 10453909
[No Abstract] [Full Text] [Related]
3. Dr. Brent and scientific debate.
Newman SA
Reprod Toxicol; 1999; 13(4):241-4. PubMed ID: 10453908
[No Abstract] [Full Text] [Related]
4. Response to Dr. Brent's commentary on "Dr. Brent and scientific debate".
Newman SA
Reprod Toxicol; 1999; 13(4):255-60. PubMed ID: 10532797
[No Abstract] [Full Text] [Related]
5. Bendectin.
DeSesso JM
Reprod Toxicol; 2001; 15(6):733. PubMed ID: 11738529
[No Abstract] [Full Text] [Related]
6. Bendectin: review of the medical literature of a comprehensively studied human nonteratogen and the most prevalent tortogen-litigen.
Brent RL
Reprod Toxicol; 1995; 9(4):337-49. PubMed ID: 7496090
[TBL] [Abstract][Full Text] [Related]
7. Bendectin--birth defects controversy.
Newman SA
JAMA; 1990 Aug; 264(5):569-70. PubMed ID: 2366291
[No Abstract] [Full Text] [Related]
8. Bendectin case dismissed.
Barinaga M
Science; 1995 Jan; 267(5195):167. PubMed ID: 7809619
[No Abstract] [Full Text] [Related]
9. Additional follow-up of congenital limb disorders in relation to Bendectin use.
Aselton PJ; Jick H
JAMA; 1983 Jul; 250(1):33-4. PubMed ID: 6682906
[No Abstract] [Full Text] [Related]
10. Bendectin/diclectin for morning sickness: a Canadian follow-up of an American tragedy.
Ornstein M; Einarson A; Koren G
Reprod Toxicol; 1995; 9(1):1-6. PubMed ID: 8520127
[No Abstract] [Full Text] [Related]
11. Is Bendectin a teratogen?
Cordero JF; Oakley GP; Greenberg F; James LM
JAMA; 1981 Jun; 245(22):2307-10. PubMed ID: 7230458
[TBL] [Abstract][Full Text] [Related]
12. Bendectin and fetal development. A study of Boston City Hospital.
Morelock S; Hingson R; Kayne H; Dooling E; Zuckerman B; Day N; Alpert JJ; Flowerdew G
Am J Obstet Gynecol; 1982 Jan; 142(2):209-13. PubMed ID: 7055187
[TBL] [Abstract][Full Text] [Related]
13. Admissibility of scientific testimony into evidence.
Brushwood DB
Am J Hosp Pharm; 1994 Mar; 51(5):683-5. PubMed ID: 8203391
[No Abstract] [Full Text] [Related]
14. Bendectin: a case of mourning sickness.
Hays DP
Drug Intell Clin Pharm; 1983 Nov; 17(11):826-7. PubMed ID: 6641507
[No Abstract] [Full Text] [Related]
15. How safe is Bendectin?
Kolata GB
Science; 1980 Oct; 210(4469):518-9. PubMed ID: 7423201
[No Abstract] [Full Text] [Related]
16. Jury clears Bendectin.
Kolata G
Science; 1985 Mar; 227(4694):1559. PubMed ID: 3975625
[No Abstract] [Full Text] [Related]
17. Debendox is not thalidomide.
Lancet; 1984 Jul; 2(8396):205-6. PubMed ID: 6146759
[No Abstract] [Full Text] [Related]
18. The innocent bystander. Doxylamine/dicyclomine/pyridoxine and congenital limb defects.
McCredie J; Kricker A; Elliott J; Forrest J
Med J Aust; 1984 Apr; 140(9):525-7. PubMed ID: 6708895
[TBL] [Abstract][Full Text] [Related]
19. Debendox in the dock.
Brown A
Nurs Mirror; 1980 Feb; 150(8):8-9. PubMed ID: 6899313
[No Abstract] [Full Text] [Related]
20. The Bendectin debate.
Korcok M
Can Med Assoc J; 1980 Nov; 123(9):922-8. PubMed ID: 7437993
[No Abstract] [Full Text] [Related]
[Next] [New Search]